⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9546174 | 0.92 | — | — | |
| SCHEMBL10619335 | 0.84 | PPARG (0.30) | — | |
| SCHEMBL9546356 | 0.79 | PTGER3 (0.43) | — | |
| SCHEMBL9546354 | 0.79 | PTGER3 (0.43) | — | |
| SCHEMBL9546104 | 0.76 | PDE4D (0.36) | — | |
| SCHEMBL9546101 | 0.76 | PPARG (0.33) | — | |
| SCHEMBL9546184 | 0.75 | EPHX2 (0.42) | — | |
| SCHEMBL9546183 | 0.75 | EPHX2 (0.42) | — | |
| SCHEMBL9546383 | 0.74 | PPARG (0.31) | — | |
| SCHEMBL9546268 | 0.71 | PTGER3 (0.43) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5216183-A | Antitumor, anticarcinogenic agents; bone formation accelerators | TEIJIN LIMITED (JP) | 1993-06-01 | — | — | US | disclosed |
| EP-0338796-B1 | 2-SUBSTITUTED-2-CYCLOPENTENONES | TEIJIN LIMITED (JP) | 1993-03-10 | — | — | EP | disclosed |
| US-5116869-A | Antitumor Agents, Bone Formation Accelerator | TEIJIN LIMITED (JP) | 1992-05-26 | — | — | US | disclosed |
| EP-0338796-A2 | 2-Substituted-2-cyclopentenones | TEIJIN LIMITED (JP) | 1989-10-25 | — | — | EP | disclosed |